During the past decade, Swinburne University conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Swinburne University" #1 collaborator was "Australian and New Zealand College of Anaesthetists" with 1 trials as a collaborator and "Biopharmica Limited" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Swinburne University" are "Depth of Anaesthesia" (2 trials). Many other conditions were trialed in "Swinburne University" in a lesser frequency.

Most popular intervention types in "Swinburne University" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Nitrous oxide" (1 trials) and "remifentanil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Swinburne University" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Swinburne University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Swinburne University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Swinburne University, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".